Novel Implications in Molecular Diagnosis of Lynch Syndrome

About 10% of total colorectal cancers are associated with known Mendelian inheritance, as Familial Adenomatous Polyposis (FAP) and Lynch syndrome (LS). In these cancer types the clinical manifestations of disease are due to mutations in high-risk alleles, with a penetrance at least of 70%. The LS is...

Full description

Saved in:
Bibliographic Details
Main Authors: Raffaella Liccardo, Marina De Rosa, Paola Izzo, Francesca Duraturo
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2017/2595098
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563828821327872
author Raffaella Liccardo
Marina De Rosa
Paola Izzo
Francesca Duraturo
author_facet Raffaella Liccardo
Marina De Rosa
Paola Izzo
Francesca Duraturo
author_sort Raffaella Liccardo
collection DOAJ
description About 10% of total colorectal cancers are associated with known Mendelian inheritance, as Familial Adenomatous Polyposis (FAP) and Lynch syndrome (LS). In these cancer types the clinical manifestations of disease are due to mutations in high-risk alleles, with a penetrance at least of 70%. The LS is associated with germline mutations in the DNA mismatch repair (MMR) genes. However, the mutation detection analysis of these genes does not always provide informative results for genetic counseling of LS patients. Very often, the molecular analysis reveals the presence of variants of unknown significance (VUSs) whose interpretation is not easy and requires the combination of different analytical strategies to get a proper assessment of their pathogenicity. In some cases, these VUSs may make a more substantial overall contribution to cancer risk than the well-assessed severe Mendelian variants. Moreover, it could also be possible that the simultaneous presence of these genetic variants in several MMR genes that behave as low risk alleles might contribute in a cooperative manner to increase the risk of hereditary cancer. In this paper, through a review of the recent literature, we have speculated a novel inheritance model in the Lynch syndrome; this could pave the way toward new diagnostic perspectives.
format Article
id doaj-art-1e6abf17255b4662b3dd22caf9d7be3c
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-1e6abf17255b4662b3dd22caf9d7be3c2025-02-03T01:12:26ZengWileyGastroenterology Research and Practice1687-61211687-630X2017-01-01201710.1155/2017/25950982595098Novel Implications in Molecular Diagnosis of Lynch SyndromeRaffaella Liccardo0Marina De Rosa1Paola Izzo2Francesca Duraturo3Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, 80131 Naples, ItalyAbout 10% of total colorectal cancers are associated with known Mendelian inheritance, as Familial Adenomatous Polyposis (FAP) and Lynch syndrome (LS). In these cancer types the clinical manifestations of disease are due to mutations in high-risk alleles, with a penetrance at least of 70%. The LS is associated with germline mutations in the DNA mismatch repair (MMR) genes. However, the mutation detection analysis of these genes does not always provide informative results for genetic counseling of LS patients. Very often, the molecular analysis reveals the presence of variants of unknown significance (VUSs) whose interpretation is not easy and requires the combination of different analytical strategies to get a proper assessment of their pathogenicity. In some cases, these VUSs may make a more substantial overall contribution to cancer risk than the well-assessed severe Mendelian variants. Moreover, it could also be possible that the simultaneous presence of these genetic variants in several MMR genes that behave as low risk alleles might contribute in a cooperative manner to increase the risk of hereditary cancer. In this paper, through a review of the recent literature, we have speculated a novel inheritance model in the Lynch syndrome; this could pave the way toward new diagnostic perspectives.http://dx.doi.org/10.1155/2017/2595098
spellingShingle Raffaella Liccardo
Marina De Rosa
Paola Izzo
Francesca Duraturo
Novel Implications in Molecular Diagnosis of Lynch Syndrome
Gastroenterology Research and Practice
title Novel Implications in Molecular Diagnosis of Lynch Syndrome
title_full Novel Implications in Molecular Diagnosis of Lynch Syndrome
title_fullStr Novel Implications in Molecular Diagnosis of Lynch Syndrome
title_full_unstemmed Novel Implications in Molecular Diagnosis of Lynch Syndrome
title_short Novel Implications in Molecular Diagnosis of Lynch Syndrome
title_sort novel implications in molecular diagnosis of lynch syndrome
url http://dx.doi.org/10.1155/2017/2595098
work_keys_str_mv AT raffaellaliccardo novelimplicationsinmoleculardiagnosisoflynchsyndrome
AT marinaderosa novelimplicationsinmoleculardiagnosisoflynchsyndrome
AT paolaizzo novelimplicationsinmoleculardiagnosisoflynchsyndrome
AT francescaduraturo novelimplicationsinmoleculardiagnosisoflynchsyndrome